Photoswitchable anticancer activity via trans-cis isomerization of a combretastatin A-4 analog.

about

Emerging Targets in Photopharmacology.Light induced drug release from a folic acid-drug conjugate.Azobenzene photocontrol of peptides and proteins.Molecular Motors in Aqueous Environment

P2860

Q38845495-CC2565D0-5C48-41B1-9485-B9D7F2D0DCD4 Q45049944-5B0F4D09-FD63-4A53-A43D-44A32CAB9EF7 Q51562229-CB23B39D-8680-4FFD-A87A-A26EE9E8BE20 Q58717799-20DCC94D-0F7C-430E-BE2D-2275DE4B6221

P2860

Photoswitchable anticancer activity via trans-cis isomerization of a combretastatin A-4 analog.

Item

http://www.wikidata.org/entity/Q36378377

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Photoswitchable anticancer act ...... f a combretastatin A-4 analog.

@ast

Photoswitchable anticancer act ...... f a combretastatin A-4 analog.

@en

type

Item

label

Photoswitchable anticancer act ...... f a combretastatin A-4 analog.

@ast

Photoswitchable anticancer act ...... f a combretastatin A-4 analog.

@en

prefLabel

Photoswitchable anticancer act ...... f a combretastatin A-4 analog.

@ast

Photoswitchable anticancer act ...... f a combretastatin A-4 analog.

@en

P1476

Photoswitchable anticancer act ...... of a combretastatin A-4 analog

@en

P2093

Charles E Lyons

http://www.w3.org/2001/XMLSchema#string

Jonathon E Sheldon

http://www.w3.org/2001/XMLSchema#string

Matthew C T Hartman

http://www.w3.org/2001/XMLSchema#string

P2860

Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic results.

Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT.

Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release.

Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate.

Near-infrared light-sensitive liposomes for the enhanced photothermal tumor treatment by the combination with chemotherapy

Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling.

Photodynamic therapy for cancer.

Optical control of insulin release using a photoswitchable sulfonylurea

Photoswitchable Inhibitors of Microtubule Dynamics Optically Control Mitosis and Cell Death.

A model for cleavage plane determination in early amphibian and fish embryos.

P304

40-49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C5OB02005K

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

John C. Hackett

M Michael Dcona

P577

2015-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283293661

http://www.w3.org/2001/XMLSchema#string

P698

26503632

http://www.w3.org/2001/XMLSchema#string

P932

4681686

http://www.w3.org/2001/XMLSchema#string

Photoswitchable anticancer activity via trans-cis isomerization of a combretastatin A-4 analog.

about

P2860

P2860

Photoswitchable anticancer activity via trans-cis isomerization of a combretastatin A-4 analog.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932